Report of Foreign Issuer (6-k)
April 26 2019 - 9:35AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, April 2019
Commission File Number 001-37652
Midatech Pharma PLC
(Translation of registrant’s name
into English)
Oddfellows House
19 Newport Road
Cardiff, CF24 0AA, United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
NASDAQ Minimum Bid Price
As previously disclosed,
on May 1, 2018, the NASDAQ Stock Market LLC (“NASDAQ”) notified Midatech Pharma PLC (the “Company”) that
its American Depositary Shares had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days
as required under the NASDAQ Listing Rules.
On April 23, 2019,
the Company received a letter from NASDAQ that for the last 10 consecutive business days, from April 8 to April 22, 2019, the closing
bid price of the Company’s American Depositary Shares had been at $1.00 per share or greater and, accordingly, the Company
has regained compliance with NASDAQ Listing Rule 5550(a)(2), and the matter is now closed.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
Midatech Pharma PLC
|
|
|
|
Date: April 26, 2019
|
By:
|
/s/ Nicholas Robbins-Cherry
|
|
|
Nicholas Robbins-Cherry
Chief Financial Officer
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2023 to Apr 2024